ERYTECH Pharma (NASDAQ:ERYP) Shares Down 5.7%

Posted by on Apr 7th, 2023

ERYTECH Pharma S.A. (NASDAQ:ERYP – Get Rating) fell 5.7% on Thursday . The stock traded as low as $0.82 and last traded at $0.84. 10,420 shares traded hands during trading, a decline of 71% from the average session volume of 35,362 shares. The stock had previously closed at $0.89.

ERYTECH Pharma Trading Down 5.7 %

The firm has a fifty day moving average price of $0.88 and a two-hundred day moving average price of $0.68. The company has a debt-to-equity ratio of 0.32, a quick ratio of 3.65 and a current ratio of 3.65.

Hedge Funds Weigh In On ERYTECH Pharma

An institutional investor recently bought a new position in ERYTECH Pharma stock. Jefferies Financial Group Inc. bought a new position in ERYTECH Pharma S.A. (NASDAQ:ERYP – Get Rating) during the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 572,698 shares of the company’s stock, valued at approximately $189,000. Jefferies Financial Group Inc. owned 1.85% of ERYTECH Pharma as of its most recent filing with the SEC. 4.79% of the stock is owned by institutional investors and hedge funds.

ERYTECH Pharma Company Profile

(Get Rating)

ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France.

See Also

Receive News & Ratings for ERYTECH Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ERYTECH Pharma and related companies with MarketBeat.com's FREE daily email newsletter.